Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG block for postoperative pain after peri-acetabular osteotomy
2024-513688-25-01Phase 4Authorised
- Sponsor
- Rigshospitalet
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing PENG block with ropivacaine with PENG block with saline placebo (2 arms). Primary endpoint: Area under curve (AUC) of pain on NRS 0–10 in first 24 hours postoperatively. Planned start Jun 2024; status: authorised.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2024-513688-25-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513688-25-01.